(주)셀진

{
  "address": "경기 성남시",
  "ceo_name": "손세일",
  "certificate": [
    {
      "cert_number": "20180114313",
      "changes": "",
      "disclosure_date": "2018-12-19",
      "first_cert_date": "2018-12-19",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-12-19 ~ 2020-12-18"
    },
    {
      "cert_number": "20200114209",
      "changes": "",
      "disclosure_date": "2020-11-03",
      "first_cert_date": "2018-12-19",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-12-19 ~ 2022-12-18"
    },
    {
      "cert_number": "20221130030071",
      "changes": "",
      "disclosure_date": "2022-11-30",
      "first_cert_date": "2018-12-19",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2022-12-19 ~ 2025-12-18"
    },
    {
      "cert_number": "20251223030076",
      "changes": "",
      "disclosure_date": "2025-12-23",
      "first_cert_date": "2018-12-19",
      "no": "4",
      "type": "혁신성장유형",
      "valid_period": "2025-12-19 ~ 2028-12-18"
    }
  ],
  "company_name": "(주)셀진",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 10000000,
      "cost_of_sales": 2074000,
      "current_assets": 20283000,
      "current_liabilities": 140890000,
      "gross_profit": 101429000,
      "net_income": 647000,
      "net_income_bs": 646000,
      "non_current_assets": 52870000,
      "non_current_liabilities": 20000000,
      "non_operating_expenses": 402000,
      "non_operating_income": 38002000,
      "operating_profit": -36953000,
      "revenue": 103503000,
      "sga_expenses": 138382000,
      "total_assets": 73153000,
      "total_equity": -87737000,
      "total_liabilities": 160890000
    },
    "2023": {
      "capital_stock": 10000000,
      "cost_of_sales": 0,
      "current_assets": 15847000,
      "current_liabilities": 188244000,
      "gross_profit": 82054000,
      "net_income": -33024000,
      "net_income_bs": -33025000,
      "non_current_assets": 56367000,
      "non_current_liabilities": 4731000,
      "non_operating_expenses": 5030000,
      "non_operating_income": 18073000,
      "operating_profit": -46067000,
      "revenue": 82054000,
      "sga_expenses": 128121000,
      "total_assets": 72214000,
      "total_equity": -120762000,
      "total_liabilities": 192976000
    },
    "2024": {
      "capital_stock": 10000000,
      "cost_of_sales": 0,
      "current_assets": 32888000,
      "current_liabilities": 245510000,
      "gross_profit": 69736000,
      "net_income": -33418000,
      "net_income_bs": -33419000,
      "non_current_assets": 58441000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 0,
      "non_operating_income": 23000,
      "operating_profit": -33441000,
      "revenue": 69736000,
      "sga_expenses": 103177000,
      "total_assets": 91329000,
      "total_equity": -154181000,
      "total_liabilities": 245510000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "의료기기 개발",
  "phone": "010-2405-****",
  "years": [
    2024,
    2023,
    2022
  ]
}